FingerprintDive into the research topics of 'RTOG 0522: Huge investment in patients and resources and no benefit with addition of cetuximab to radiotherapy-why did this occur?'. Together they form a unique fingerprint.
- Sort by
Douglas Adkins, Jessica Ley, Tanya M. Wildes, Loren Michel
Research output: Contribution to journal › Letter › peer-review